Tenet Healthcare Corporation

    Jurisdiction
    United States
    LEI
    0W9AIBT6U6ADJ2I8HK17
    ISIN
    US88033G4073 (THC)
    Sectors
    1. Healthcare
    2. Medical - Care Facilities

    Scores

    InsiderPie Expert Score
    48 / 100
    Worse than peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Tenet Healthcare Corporation operates as a diversified healthcare services company. Read full profile

    Fundamentals

    Net revenue
    €17.65B
    Gross margin
    47.8%
    EBIT
    €3.16B
    EBIT margin
    17.9%
    Net income
    €1.27B
    Net margin
    7.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €18.78B +6.4% €1.18B -6.6%
    €19.73B +5.1% €1.24B +5.0%
    €20.06B +1.6% €1.46B +17.4%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.01
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Lynch Christopher S. N/A -8 $183.44 -$1.47K
    Foo Lisa Y EVP, Chief Operating Officer -8K $179.53 -$1.44M
    Lynch Christopher S. N/A -4K $176.39 -$697.09K

    Congress transactions

    Name Transaction date Value
    Lisa McClain September 12, 2025 $1.00K–$15.00K
    Lisa McClain August 13, 2025 $1.00K–$15.00K
    John James September 6, 2024 $1.00K–$15.00K
    John James September 2, 2024 $1.00K–$15.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 200K $26.90M -207K Sell
    Peter Brown 35K $4.74M -403K Sell

    Earnings Calls

    Latest earnings call: April 30, 2024 (Q1 2024)

    Add to watchlist

    Notifications